Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-21-012246
Filing Date
2021-09-09
Accepted
2021-09-09 21:49:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 13816
2 GRAPHIC g156228g07b01.jpg GRAPHIC 2140
  Complete submission text file 0000950123-21-012246.txt   17774
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations